Hyundai Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hyundai Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Reyon Pharmaceutical Co Ltd
sales of 121.85 billion Korean Won [US$109.05 million]
Kukje Pharma Co Ltd
(120.68 billion Korean Won [US$108.01 million]
of which 94%
was Pharmaceutical), and
Nutri Biotech Co Ltd
(120.78 billion Korean Won [US$108.10 million]
During the year ended November of 2016, sales at
Hyundai Pharmaceutical Company Limited were 120.02 billion Korean Won (US$107.42 million).
increase of 9.3%
versus 2015, when the company's sales were 109.83 billion Korean Won.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Hyundai Pharmaceutical Company Limited had sales
of 113.05 billion Korean Won.
Sales of Pharmaceutical saw an increase
10.7% in 2016, from
92.97 billion Korean Won to 102.92 billion Korean Won.